Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Colorectal Neoplasms 2Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 290Capecitabine 206Fluorouracil 181Cisplatin 168Docetaxel 138S 1 (combination) 132Paclitaxel 121Leucovorin 116Irinotecan 106pembrolizumab 103Trastuzumab 72apatinib 56Nivolumab 56sintilimab 45Drug Therapy 43Surgical Procedures, Operative 37Radiotherapy 37Bevacizumab 37Ramucirumab 34titanium silicide 31Hyperthermic Intraperitoneal Chemotherapy 30Epirubicin 30Carboplatin 30tislelizumab 28Cyclophosphamide 27XELOX 24Tegafur 23Folfox protocol 22Albumin-Bound Paclitaxel 22camrelizumab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Stomach Neoplasms × polysaccharide-K × Clear all
NCT00216034 2016-06-07

Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK

Hokuriku-Kinki Immunochemotherapy Study Group

Phase 3 Completed
255 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00687843 2012-03-22

TMOG-GC01

Tokyo Metropolitan Oncology Group

Phase 3 Unknown
480 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00503321 2009-01-23

eNCIT-Japan

Eastern Network of Cancer Immunological Therapy, Japan

Phase 2/3 Terminated
13 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡